Skip to content

OptimizeRx OPRX Preferred Stock, Shares Issued

Preferred Stock, Shares Issued at other companies

Doximity logo
DoximityDOCS
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
PubMatic logo
PubMaticPUBM
Quad Graphics logo
Quad GraphicsQUAD
UnitedHealth Group logo
UnitedHealth GroupUNH
Claritev Corporation logo
Claritev CorporationCTEV

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's preferred stock, shares issued.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's preferred stock, shares issued?
OptimizeRx (OPRX) reported preferred stock, shares issued of $0 in Q1 2026.